|
ZNF433 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.82336393048399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59970037216794E-10 |
| Normal-vs-Stage2 |
1.484070E-03 |
| Normal-vs-Stage3 |
2.70609978869629E-10 |
| Normal-vs-Stage4 |
3.10920178492324E-11 |
| Stage1-vs-Stage2 |
8.935500E-02 |
| Stage1-vs-Stage3 |
3.882200E-01 |
| Stage1-vs-Stage4 |
1.221740E-02 |
| Stage2-vs-Stage3 |
3.450100E-02 |
| Stage2-vs-Stage4 |
3.800400E-03 |
| Stage3-vs-Stage4 |
1.455410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.93165533252704E-12 |
| Normal-vs-AfricanAmerican |
7.992400E-04 |
| Normal-vs-Asian |
1.28499999529907E-08 |
| Caucasian-vs-AfricanAmerican |
5.651400E-01 |
| Caucasian-vs-Asian |
7.429800E-01 |
| AfricanAmerican-vs-Asian |
5.329000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.45089989706571E-10 |
| Normal-vs-Female |
2.54709586755553E-11 |
| Male-vs-Female |
9.815400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.88049997795758E-09 |
| Normal-vs-Age(41-60Yrs) |
6.72649713706619E-11 |
| Normal-vs-Age(61-80Yrs) |
2.76139999977332E-07 |
| Normal-vs-Age(81-100Yrs) |
3.199500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.959400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.457000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.600800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.210800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.163800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.389800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.27089999974106E-07 |
| Classical-VS-Follicular |
1.362890E-03 |
| Classical-VS-Other |
6.121600E-01 |
| Classical-VS-Normal |
6.26254603730558E-12 |
| Tall-VS-Follicular |
2.67169952827828E-10 |
| Tall-VS-Other |
1.644330E-02 |
| Tall-VS-Normal |
1.64568358940187E-12 |
| Follicular-VS-Other |
1.698490E-02 |
| Follicular-VS-Normal |
2.235800E-03 |
| Other-VS-Normal |
2.10829999999218E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.46540000029094E-07 |
| Normal-vs-N1 |
8.24851298375506E-12 |
| N0-vs-N1 |
1.376520E-04 |
|
|
